Viewing Study NCT02120157

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:34 PM
Ignite Modification Date: 2026-05-28 @ 5:31 AM
Study NCT ID: NCT02120157
Status: COMPLETED
Last Update Posted: 2021-11-26
First Post: 2014-04-16
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myeloablative Conditioning View
None HLA-mismatched Bone Marrow Transplantation View
None Graft Survival View
None Transplantation, Bone Marrow View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Acute lymphoblastic leukemia View
None Acute myeloid leukemia View
None Juvenile myelomonocytic leukemia View
None Treatment related leukemia View
None Biphenotypic leukemia View